News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 52451
- Sources here
- 25
- Companies here
- 38
Active search
52451 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
COGT Maintained by Piper Sandler -- Price Target Raised to $55
Piper Sandler has maintained an "Overweight" rating for Cogent Biosciences (COGT) and raised its price target to $55.00, reflecting increased confidence in the company's potential, especially for its precision therapy program CGT9486. Despite this positive analyst outlook, Cogent Biosciences has a low GF Score™ …
HPE stock advances after DOJ clears Juniper acquisition
HPE stock has advanced significantly after the U.S. Justice Department cleared its acquisition of Juniper Networks. The deal aims to strengthen HPE's networking and AI-driven cloud portfolio, with investors weighing the strategic benefits. Analysts have a moderate buy rating with a consensus target price …
Lumentum (LITE) Stock Looks Fully Priced Despite Cash Flow Upside
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Lumentum Holdings has turned into a very strong performer over the past few years, …
Sharemaestro market context Trend signal active 52 weeks +568.7% · Next-week setup negative 37.5%Genuine Parts Co. stock underperforms Monday when compared to competitors
Genuine Parts Co. (GPC) stock declined by 1.86% to $132.52 on Monday, underperforming the broader market. This drop occurred on a negative trading day where the S&P 500 Index fell 0.52% and the Dow Jones Industrial Average dropped 0.51%. This marked the second consecutive …
Kaplan Fox Reminds Pentair plc (NYSE: PNR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on October 2, 2026
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Pentair plc (NYSE: PNR) on behalf of investors who suffered losses between April 28, 2026, and July 14, 2026. The lawsuit was prompted by a significant drop in Pentair's stock price after …
Nano Nuclear Is Still Under $20. Here's My Case for Why That Won't Last.
It's been a rough year for Nano Nuclear Energy's (NASDAQ: NNE) stock. In the past 12 months, shares of the nuclear energy company have stumbled more than 40% and are now trading around $20. This pullback feels overdone, though, and I don't believe Nano …
Form 8K LEXARIA BIOSCIENCE CORP. For: 17 August By Investing.com
This article announces that LEXARIA BIOSCIENCE CORP. filed a Form 8K on August 17. The filing is brief, providing only the date and company name, and includes current stock market data and trending stock information.
ServiceNow Was the Face of the SaaS Panic. Its Q2 Numbers Told a Different Story
ServiceNow's Q2 earnings report demonstrated strong performance, with AI annual contract value (ACV) exceeding $1 billion and subscription revenue growing 23% in constant currency, despite market skepticism. While the stock initially dipped due to broader market concerns and a new competitive offering from OpenAI, …
argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement
argenx SE (ARGX) stock surged by 16.67% on August 17, driven primarily by positive Phase 3 ALKIVIA study results for VYVGART Hytrulo in autoimmune myositis. The company reported strong financials with $4.15 billion in annual revenue and $1.29 billion in net profit, further boosting …
Lexaria Bioscience regains Nasdaq bid-price compliance, listing continued
Lexaria Bioscience (LEXX) has successfully regained compliance with Nasdaq's $1.00 bid-price requirement and will maintain its listing on The Nasdaq Capital Market. Nasdaq confirmed that the company met Listing Rule 5550(a)(2) on August 17, 2026, leading to the cancellation of the previously scheduled Nasdaq …
Valero Energy Corp. stock outperforms competitors on strong trading day
Valero Energy Corp. (VLO) saw its stock rise by 1.62% to $347.19 on Monday, outperforming the broader market which experienced a poor trading session with the S&P 500 and Dow Jones Industrial Average both falling. The company's stock also hit a new 52-week high, …
Dominion Energy Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dominion Energy, Inc. - D
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Dominion Energy, Inc. (NYSE: D) to NextEra Energy, Inc. (NYSE: NEE). KSF is examining whether the proposed consideration of 0.8138 shares of NextEra for each share of Dominion adequately values Dominion, or …
Sharemaestro market context Trend signal active 52 weeks +16.0% · Next-week setup positive 56.1%Delisting risk eases as Lexaria (NASDAQ: LEXX) regains bid-price compliance
Lexaria Bioscience Corp. (NASDAQ: LEXX) has regained compliance with Nasdaq's minimum bid price requirement, removing the immediate risk of delisting. Nasdaq confirmed Lexaria's compliance on August 17, 2026, leading to the cancellation of a previously scheduled hearing. As a result, Lexaria's common stock will …
Generation Income Properties reports Q2 results
* Generation Income Properties press release [https://seekingalpha.com/pr/20620970-generation-income-properties-announces-second-quarter-2026-financial-results-and-provides] (GIPR [https://seekingalpha.com/symbol/GIPR]): Q2 net loss attributable to common shareholders was $1.08M. * Revenue of $2.11M misses by $0.01M. MORE ON GENERATION INCOME PROPERTIES * Seeking Alpha’s Quant Rating on Generation Income Properties [https://seekingalpha.com/symbol/GIPR/ratings/quant-ratings] * Historical earnings data …
Earnings Estimates Moving Higher for Valero Energy (VLO): Time to Buy?
Valero Energy (VLO) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving. The rising trend in estimate revisions, …
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup negative 37.4%In Win for Gilead, Fourth Circuit Affirms Injunction Blocking Drug Importation Scheme
The Fourth Circuit Court of Appeals affirmed a preliminary injunction against several entities for importing, advertising, and facilitating the importation of foreign-market Gilead Sciences, Inc. medications into the United States. The court found that the imported drugs were not "genuine" under the Lanham Act …
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Tenax Therapeutics (TENX)
Levi & Korsinsky, LLP is investigating potential securities law violations involving Tenax Therapeutics (TENX) after its shares dropped 84-85%. This significant decline followed the disclosure that the Phase 3 LEVEL trial of its lead drug, TNX-103, failed to meet both its primary and key …
Should Investors Hold Enbridge as Growth Faces a Premium Valuation?
Enbridge Inc. (ENB) offers long-term contracted cash flows, a significant backlog, and a 5.4% dividend yield, with management foreseeing substantial organic growth opportunities through 2030. However, the company faces a premium valuation compared to its industry, the S&P 500, and its historical median, alongside …
Sharemaestro market context Trend signal ended 52 weeks +10.8% · Next-week setup positive 60.6%Pacira BioSciences (NASDAQ: PCRX) faces $70.6K share sale in 2026
Pacira BioSciences (NASDAQ: PCRX) is set to see a proposed sale of 3,040 common shares with an aggregate market value of $70,619.20 on August 17, 2026. The sale, detailed in a Form 144 SEC filing, will be executed through Fidelity Brokerage Services LLC on …
Dominion Energy shares steps to trim down AC bills as record breaking heat sets in
As record-breaking temperatures hit the Lowcountry, Dominion Energy is offering essential tips to help customers save on their air conditioning bills. Recommendations include setting thermostats to 78 degrees or higher, using fans to supplement cooling, and performing regular maintenance on HVAC systems and home …
Penske Commercial Truck Sales Rise as Q2 Revenue Declines
Penske Automotive Group reported increased retail commercial truck sales in Q2 2026, with 5,431 units sold, despite a decline in commercial truck revenue to $927.8 million and pre-tax income to $47.2 million. The company attributed the revenue decline to weak truck order intake in …
Devon Energy (NYSE:DVN) Given Buy Rating at Argus
Argus has reiterated its "buy" rating for Devon Energy (NYSE:DVN) and set a $45.85 price target. This aligns with a "Moderate Buy" consensus among analysts, with an average target of $59.15 for the energy company. Devon Energy recently exceeded quarterly earnings expectations, reporting $1.57 …
CPT Maintained by Barclays -- Price Target Raised to $123
Barclays has maintained an Equal-Weight rating for Camden Property Trust (CPT) and slightly increased its price target from $122.00 to $123.00. Despite no insider buying, GuruFocus indicates CPT is undervalued by 2.7% with a GF Value™ of $112.72 against its current price of $109.67, …